A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 (Q28943270)

14 March 2017

title

A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 (English)

1 reference

genome-wide association study

14 March 2017

main subject

0 references

1 reference

5

Michiaki Kubo

1 reference

14 March 2017

9

0 references

Dylan Glubb

13

object named as

Dylan Glubb

1 reference

14 March 2017

20

Yusuke Nakamura

1 reference

14 March 2017

21

Mark J. Ratain

1 reference

14 March 2017

1

Federico Innocenti

1 reference

14 March 2017

3

Nancy L. Cox

1 reference

14 March 2017

6

Hitoshi Zembutsu

1 reference

14 March 2017

11

Paula Friedman

1 reference

14 March 2017

12

Liewei Wang

1 reference

14 March 2017

16

Howard L. McLeod

1 reference

14 March 2017

19

Hedy L. Kindler

1 reference

14 March 2017

Kouros Owzar

2

1 reference

14 March 2017

Patrick Evans

4

1 reference

14 March 2017

Chen Jiang

7

1 reference

14 March 2017

Donna Hollis

8

1 reference

14 March 2017

Liang Li

10

1 reference

14 March 2017

Herbert Hurwitz

14

1 reference

14 March 2017

Kathleen M. Giacomini

15

1 reference

14 March 2017

Richard M. Goldberg

17

1 reference

14 March 2017

Richard L. Schilsky

18

1 reference

14 March 2017

language of work or name

English

0 references

publication date

15 January 2012

1 reference

14 March 2017

published in

Clinical Cancer Research

1 reference

14 March 2017

volume

18

1 reference

14 March 2017

issue

2

1 reference

14 March 2017

page(s)

577–584

1 reference

describes a project that uses

14 March 2017

genome-wide association study

1 reference

Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers

inferred from title

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

The genomic landscapes of human breast and colorectal cancers

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Principal components analysis corrects for stratification in genome-wide association studies

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Pathways for aberrant angiogenesis in pancreatic cancer

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

16 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

The use of genomic information to optimize cancer chemotherapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Molecular epidemiology and its current clinical use in cancer management

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

SCAN: SNP and copy number annotation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

WWOX: its genomics, partners, and functions

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Pancreatic cancer: current and future treatment strategies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Japanese single nucleotide polymorphism database for 267 possible drug-related genes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Multiple Genetic Loci Modulate Lung Adenocarcinoma Clinical Staging

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

APC/CTNNB1 (?-catenin) pathway alterations in human prostate cancers

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3412624

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

26 November 2018

1 reference

12 December 2020

IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity

1 reference

12 December 2020

Genetic polymorphisms of molecules associated with inflammation and immune response in Japanese subjects with functional dyspepsia

1 reference

12 December 2020

The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis

1 reference

12 December 2020

Increase in incidence of colorectal cancer among young men and women in the United States

1 reference

12 December 2020

10.1158/1078-0432.CCR-11-1387

Identifiers

DOI

1 reference

14 March 2017

0 references

1 reference